HOME >> MEDICINE >> NEWS
NHLBI funds asthma coalitions to improve care among high risk populations

Asthma coalitions in seven communities with exceptionally high asthma death rates have been awarded contracts by the National Heart, Lung, and Blood Institute (NHLBI). The contracts are designed to establish partnerships between the NHLBI and local asthma coalitions to develop innovative, model programs for improving asthma care. The coalitions will implement activities to eliminate disparities in asthma morbidity and mortality in their communities, especially among children, minorities, and low-income individuals.

According to NHLBI Director Dr. Claude Lenfant, "We now know enough about asthma so that no one should die from it any more. Yet people are still dying from asthma. Why? Because the information about how best to treat and control it is not being widely used. By forging partnerships with coalitions in high-risk communities, we can bring this information directly to the people who need it most."

"This is the first step in a broader plan to build a network of coalitions in high-risk communities to work together towards achieving the Healthy People 2010 goals of eliminating racial and ethnic disparities in health care," he added.

The NHLBI has a lead role in achieving the Healthy People 2010 goals in the Respiratory Diseases focus area. Eliminating racial and ethnic disparities in health care is a major Healthy People 2010 goal.

Asthma is a chronic lung condition that disproportionately affects children, minorities, and low-income individuals. Minority populations, particularly African Americans and Hispanics, account for a disproportionate share of asthma deaths, as well as emergency department visits and hospitalizations. Asthma also continues to be one of the leading causes of school absenteeism, limitations of activity, and disruption of family life in the U.S. The cost of asthma in the U.S. in 1998 was estimated at $11.3 billion.

The NHLBI created the National Asthma Education and Prevention Program (NAEPP) to im
'"/>

Contact: Ellen Sommer
sommere@nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
16-Feb-2000


Page: 1 2 3

Related medicine news :

1. NHLBI study shows smoking cessation programs improve survival
2. Frequent fast food meals increase weight, diabetes risk, NHLBI study says
3. NHLBI statement on oral contraceptive study
4. NHLBI stops sickle cell anemia transfusion study
5. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
6. Former NHLBI director Lenfant receives Lifetime Achievement Award
7. NHLBI study finds hostility, impatience increase hypertension risk
8. NHLBI study finds moderate physical activity promotes weight loss as well as intense exercise
9. NHLBI funds new heart-health education projects in high-risk communities
10. NHLBI study shows weight concerns increase girls risk of becoming smokers
11. NHLBI study shows vast majority of middle-aged Americans at risk of developing hypertension

Post Your Comments:
(Date:5/21/2013)... 2013 Standard advice for mattress shoppers ... else. However given industry’s less than exceptional satisfaction ratings ... the internet, Consumer Mattress Reports sets out to revise ... Best Mattress .” , This article addresses several components ... that may not be readily apparent to many shoppers. ...
(Date:5/21/2013)... 2013 DISCcert has served the training ... use 17 DISC applications at the July 25 & ... , The July 25 & 26th DISC certification in ... of applying DISC. The time-tested, proven support materials will ... DISC training materials ; worksheets, handouts, learning ...
(Date:5/21/2013)... 2013 Parker Waichman LLP, a national ... injured by defective medical devices, is addressing new research ... on May 15, 2013. The study found that magnetic ... that occur in patients with metal-on-metal hip implants even ... ) , “We’ve known for quite ...
(Date:5/21/2013)... France: The Orsiro stent, which is a novel ... demonstrated non-inferiority to the Xience Prime everolimus-eluting stent ... lumen loss at nine months in the results ... today. , The BIOFLOW-II substudy used intravascular ultrasound ... assess neointimal hyperplasia and stent apposition at nine ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Phoseon Technology ... at the 20th Annual IMI European Ink Jet ... proven market leader, Phoseon continues to invest in product ... the adoption of UV LED curing in printing applications. ... families on the market offering both air cooled and ...
Breaking Medicine News(10 mins):Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May ... SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... published online the positive Phase 2a study results of ... is an investigational monoclonal antibody targeting the alpha subunit ... signaling of both IL-4 and IL-13, drivers of Th2 ...
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue:   ... Scenario for Medical Devices in the US ...   Changing Regulatory and Reimbursement ... Market   Summary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: